Inger Løbersli

598 total citations
11 papers, 396 citations indexed

About

Inger Løbersli is a scholar working on Endocrinology, Infectious Diseases and Food Science. According to data from OpenAlex, Inger Løbersli has authored 11 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, 6 papers in Infectious Diseases and 5 papers in Food Science. Recurrent topics in Inger Løbersli's work include Escherichia coli research studies (8 papers), Viral gastroenteritis research and epidemiology (6 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Inger Løbersli is often cited by papers focused on Escherichia coli research studies (8 papers), Viral gastroenteritis research and epidemiology (6 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Inger Løbersli collaborates with scholars based in Norway and Germany. Inger Løbersli's co-authors include Bjørn-Arne Lindstedt, Lin T. Brandal, Amir Moghaddam, Georg Kapperud, Michael Braunagel, Ole J. Marvik, Heidi Lange, Line Vold, Astrid Louise Wester and Ole Henrik Brekke and has published in prestigious journals such as Applied and Environmental Microbiology, Journal of General Virology and Journal of Immunological Methods.

In The Last Decade

Inger Løbersli

11 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inger Løbersli Norway 11 215 174 127 111 94 11 396
Emily J. Kay United Kingdom 10 81 0.4× 107 0.6× 178 1.4× 33 0.3× 66 0.7× 15 395
Mojun Zhao United States 9 229 1.1× 173 1.0× 76 0.6× 12 0.1× 92 1.0× 12 410
Lorraine Endersen Ireland 7 109 0.5× 109 0.6× 165 1.3× 34 0.3× 131 1.4× 7 517
Michèle Mouricout France 10 139 0.6× 39 0.2× 190 1.5× 33 0.3× 79 0.8× 14 363
Ana Luisa Toribio United Kingdom 10 145 0.7× 105 0.6× 212 1.7× 18 0.2× 86 0.9× 16 468
M. Stamm Switzerland 6 289 1.3× 181 1.0× 79 0.6× 13 0.1× 92 1.0× 7 381
Massimiliano Gavini Italy 10 157 0.7× 177 1.0× 67 0.5× 17 0.2× 170 1.8× 12 380
Alison S. Low United Kingdom 8 163 0.8× 169 1.0× 100 0.8× 14 0.1× 59 0.6× 10 408
Jessica Sacher Canada 12 53 0.2× 78 0.4× 169 1.3× 49 0.4× 65 0.7× 20 454

Countries citing papers authored by Inger Løbersli

Since Specialization
Citations

This map shows the geographic impact of Inger Løbersli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Løbersli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Løbersli more than expected).

Fields of papers citing papers by Inger Løbersli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Løbersli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Løbersli. The network helps show where Inger Løbersli may publish in the future.

Co-authorship network of co-authors of Inger Løbersli

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Løbersli. A scholar is included among the top collaborators of Inger Løbersli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Løbersli. Inger Løbersli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Naseer, Umaer, et al.. (2017). Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992–2013. European Journal of Clinical Microbiology & Infectious Diseases. 36(9). 1613–1620. 31 indexed citations
2.
Lindstedt, Bjørn-Arne, et al.. (2016). Expression of Shiga toxin 2 (Stx2) in highly virulent Stx-producing Escherichia coli (STEC) carrying different anti-terminator (q) genes. Microbial Pathogenesis. 97. 1–8. 16 indexed citations
3.
Løbersli, Inger, et al.. (2016). Molecular differentiation of Shigella spp. from enteroinvasive E. coli. European Journal of Microbiology and Immunology. 6(3). 197–205. 19 indexed citations
4.
Brandal, Lin T., Astrid Louise Wester, Heidi Lange, et al.. (2015). Shiga toxin-producing escherichia coli infections in Norway, 1992–2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome. BMC Infectious Diseases. 15(1). 324–324. 69 indexed citations
5.
Brandal, Lin T., Camilla Sekse, Bjørn-Arne Lindstedt, et al.. (2012). Norwegian Sheep Are an Important Reservoir for Human-Pathogenic Escherichia coli O26:H11. Applied and Environmental Microbiology. 78(12). 4083–4091. 24 indexed citations
6.
Løbersli, Inger, et al.. (2011). Rapid and high resolution genotyping of all Escherichia coli serotypes using 10 genomic repeat-containing loci. Journal of Microbiological Methods. 88(1). 134–139. 54 indexed citations
7.
Brandal, Lin T., et al.. (2011). Detection of virulent Escherichia coli O157 strains using multiplex PCR and single base sequencing for SNP characterization. Journal of Applied Microbiology. 110(6). 1592–1600. 13 indexed citations
8.
Miko, Angelika, Bjørn-Arne Lindstedt, Lin T. Brandal, Inger Løbersli, & Lothar Beutin. (2009). Evaluation of multiple-locus variable number of tandem-repeats analysis (MLVA) as a method for identification of clonal groups among enteropathogenic, enterohaemorrhagic and avirulentEscherichia coli O26 strains. FEMS Microbiology Letters. 303(2). 137–146. 24 indexed citations
9.
Løset, Geir Åge, et al.. (2005). Construction, evaluation and refinement of a large human antibody phage library based on the IgD and IgM variable gene repertoire. Journal of Immunological Methods. 299(1-2). 47–62. 43 indexed citations
10.
Waalen, K., et al.. (2004). Neutralizing human antibodies to varicella-zoster virus (VZV) derived from a VZV patient recombinant antibody library. Journal of General Virology. 85(12). 3493–3500. 21 indexed citations
11.
Moghaddam, Amir, et al.. (2001). Selection and characterisation of recombinant single-chain antibodies to the hapten Aflatoxin-B1 from naive recombinant antibody libraries. Journal of Immunological Methods. 254(1-2). 169–181. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026